Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study
International Journal of Infectious Diseases(2022)
引用24|浏览2
暂无评分
摘要
•Multi-centric hospital-based study was conducted across 11 cities in India.•Both Covishield and Covaxin confer high protection against severe COVID-19.•Both vaccines provide high protection against severe disease by the Delta strain.•Expansion of the two-dose vaccination coverage is key to reducing hospitalizations.